2''-O-alpha-L-rhamnopyranosylhyperin-6''-O-gallate - Compound Card

2''-O-alpha-L-rhamnopyranosylhyperin-6''-O-gallate

Select a section from the left sidebar

2''-O-alpha-L-rhamnopyranosylhyperin-6''-O-gallate

Structure
Zoomed Structure
  • Family: Plantae - Anacardiaceae
  • Kingdom: Plantae
  • Class: Flavonoid
    • Subclass: Flavonol Glycoside
Canonical Smiles OC[C@H]1O[C@@H](Oc2c(oc3c(c2=O)c(O)cc(c3)O)c2c(OC(=O)c3cc(O)c(c(c3)O)O)cc(c(c2C2O[C@H](C)[C@H]([C@@H]([C@@H]2O)O)O)O)O)[C@@H]([C@H]([C@H]1O)O)O
InChI InChI=1S/C34H34O21/c1-8-21(41)26(46)28(48)30(51-8)20-19(16(6-14(40)23(20)43)53-33(50)9-2-12(38)22(42)13(39)3-9)31-32(25(45)18-11(37)4-10(36)5-15(18)52-31)55-34-29(49)27(47)24(44)17(7-35)54-34/h2-6,8,17,21,24,26-30,34-44,46-49H,7H2,1H3/t8-,17-,21-,24+,26+,27+,28+,29-,30?,34+/m1/s1
InChIKey KCGNEJMISVWXCF-CWNJIBBWSA-N
Formula C34H34O21
HBA 21
HBD 14
MW 778.63
Rotatable Bonds 7
TPSA 367.42
LogP -1.66
Number Rings 6
Number Aromatic Rings 4
Heavy Atom Count 55
Formal Charge 0
Fraction CSP3 0.35
Exact Mass 778.16
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Schinus molle Anacardiaceae Plantae 43851

Showing of synonyms

  • Marzouk MS, Moharram FA, et al. (2006). Antioxidant flavonol glycosides from Schinus molle. Phytotherapy Research,2006,20(3),200-205. [View] [PubMed]
Pubchem: 162817587
Nmrshiftdb2: 60026887

No compound-protein relationship available.

Structure

SMILES: c1ccccc1C(=O)Oc2cccc(C3CCCCO3)c2-c(oc(c45)cccc5)c(c4=O)OC6CCCCO6

Level: 4

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C(=O)Oc(cccc2)c2-c(oc(c34)cccc4)c(c3=O)OC5CCCCO5

Level: 3

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C(=O)Oc2cccc(C3CCCCO3)c2-c(cc4=O)oc(c45)cccc5

Level: 3

Mol. Weight: 778.63 g/mol

Structure

SMILES: O1CCCCC1Oc(c2=O)c(oc(c23)cccc3)-c4c(cccc4)C5CCCCO5

Level: 3

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C(=O)Oc(cccc2)c2-c(cc3=O)oc(c34)cccc4

Level: 2

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1cccc(c12)oc(-c3ccccc3)c(c2=O)OC4CCCCO4

Level: 2

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1cccc(c12)oc(cc2=O)-c3c(cccc3)C4CCCCO4

Level: 2

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C(=O)Oc(ccc2)cc2C3CCCCO3

Level: 2

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1cccc(c12)occ(c2=O)OC3CCCCO3

Level: 1

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1cccc(c12)oc(cc2=O)-c3ccccc3

Level: 1

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C(=O)Oc2ccccc2

Level: 1

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1C2CCCCO2

Level: 1

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1cccc(c12)occc2=O

Level: 0

Mol. Weight: 778.63 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 778.63 g/mol

Structure

SMILES: c1ccccc1

Level: 0

Mol. Weight: 778.63 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.49
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
8.210
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
1989.22

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.480
Plasma Protein Binding
32.85
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
10.440
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-43.960
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.140
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
7.020
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-3602053.890
Rat (Acute)
2.190
Rat (Chronic Oral)
4.720
Fathead Minnow
4555.590
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
395882.120
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-2.630
Log(P)
-0.79
Log S
-5.25
Log(Vapor Pressure)
-13036.58
Melting Point
165.98
pKa Acid
-66.67
pKa Basic
11.58
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Gag-Pol polyprotein P05896 POL_SIVM1 Simian immunodeficiency virus 4 0.8447
Gag-Pol polyprotein P05896 POL_SIVM1 Simian immunodeficiency virus 4 0.8447
WxcM-like protein Q12KT8 Q12KT8_SHEDO Shewanella denitrificans 4 0.8364
WxcM-like protein Q12KT8 Q12KT8_SHEDO Shewanella denitrificans 4 0.8364
HTH-type transcriptional repressor PurR P0ACP7 PURR_ECOLI Escherichia coli 3 0.8345
HTH-type transcriptional repressor PurR P0ACP7 PURR_ECOLI Escherichia coli 3 0.8345
HTH-type transcriptional repressor PurR P0ACP7 PURR_ECOLI Escherichia coli 3 0.7437
HTH-type transcriptional repressor PurR P0ACP7 PURR_ECOLI Escherichia coli 3 0.7437
Hypoxanthine-guanine phosphoribosyltransferase P00492 HPRT_HUMAN Homo sapiens 4 0.7283
Hypoxanthine-guanine phosphoribosyltransferase P00492 HPRT_HUMAN Homo sapiens 4 0.7283
Basic phospholipase A2 VRV-PL-VIIIa P59071 PA2B8_DABRR Daboia russelii 2 0.7239
Basic phospholipase A2 VRV-PL-VIIIa P59071 PA2B8_DABRR Daboia russelii 2 0.7239
Thymidylate synthase P0A884 TYSY_ECOLI Escherichia coli 4 0.7224
Thymidylate synthase P0A884 TYSY_ECOLI Escherichia coli 4 0.7224
Epidermal growth factor receptor P00533 EGFR_HUMAN Homo sapiens 3 0.7011
Epidermal growth factor receptor P00533 EGFR_HUMAN Homo sapiens 3 0.7011

Download SDF